clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science Spring . . . in the space of a few weeks, the drab winter grays give way to a riot of reds, pinks, yellows, and whites, as azaleas, dogwoods, and a host of other plants celebrate the arrival of longer, hotter days. But for many individuals, the bright banners of spring signal not a celebration, but a feeling of dread that augurs frequent trips to the pharmacy for the latest over-thecounter remedies. For amidst the color, another riot is taking place: in a reproductive frenzy, each member of the plant world is busily packaging its genome into protective capsules, which are ejected into the atmosphere or hitch rides on the bodies of insects. While a pollen count of 120 particles per cubic meter is considered high in many parts of the country, in the pollen belt of the southern US, counts of 6,000 are not unusual, and the accumulated particles confer a distinctly yellowish cast to the atmosphere. While Mother Nature is merely assuring the reproductive success of her immobile plant kingdom by sowing the atmosphere with these tiny portable packages of DNA, the inadvertent consequence is that many of these particles do not find their intended targets but end up in the airways and mucous membranes of hapless humans. It is no wonder that the sounds of spring are punctuated by sneezes and coughs, and that the spring colors are seen through the blur of watery, itchy eyes. Indeed, as many as 35 million people in the US suffer from allergic reactions to pollens, ranging from annoying allergic rhinitis and allergic conjunctivitis to the more dangerous allergic asthma (1).
According to established paradigms, the pollen grains are interpreted by the host as invading foreign bodies, which results in a defensive immune reaction against the proteins and other biomolecules on the pollen's surface (2) . This reaction involves inflammatory cells, including granulocytes such as eosinophils and mast cells, and can lead to chronic inflammation, airway hyperresponsiveness, bronchial constriction, increased fluid and mucus secretion, and in some cases, life-threatening sequelae (3). According to this conventional model, the inflammatory response includes the production of ROS via a membrane-associated superoxide-generating NADPH oxidase that is present in granulocytes (4, 5) . This oxidase consists of the membranebound flavocytochrome b 558 , of which gp91phox is the catalytic subunit, plus several regulatory subunits. When activated, the oxidase catalyzes the transfer of an electron from NADPH to molecular oxygen and forms superoxide (O 2
• ), with secondary production of hydrogen peroxide and other chemically reactive species (6, 7). Collectively, ROS can produce a wide range of molecular damage, which results in the oxidative modification of a variety of biomolecules as well as cellular damage and disruption of membrane integrity. In addition, ROS have more recently been implicated as intra- and intercellular signal molecules and therefore may participate more directly as mediators of the inflammatory response (8) .
According to this conventional view, if pollen acts passively to initiate the allergic reaction through its antigenic properties, then it is the host cells, including the granulocytes, that are wreaking havoc by overreacting to the pollen. However, in this issue of the JCI, Boldogh and colleagues provide evidence that pollen itself is playing an active role in triggering aspects of the host allergic response and perhaps directly damaging host cells (9) . This active role depends, ironically enough, on pollen NADPH oxidase activity, the same enzymatic activity that eosinophils trigger upon exposure to the invading pollen. According to Boldogh et al., pollen's endogenous ROS-generating activity can expose airway cells to ROS prior to the recruitment of inflammatory cells. The authors further conclude that pollen NADPH oxidase activity is involved in the recruitment of inflammatory cells, possibly through induction of IL-8 by p38 MAPK, but alone is not sufficient for such recruitment. These surprising findings represent a departure from the previous concept that ROS are derived exclusively from host immune cells during an allergic response and that their recruitment is dependent upon prior induction of an adaptive immune response.
Based on the present study, the authors propose a binary model for the induction of an inflammatory response by pollen (9) . Their model proposes that pollen NADPH oxidases provide a signal independent of the adaptive immune response that combines with the pollen antigen-induced adaptive immune response to induce allergic airway inflammation (Figure 1 ). In this model, oxidative stress produced by pollen NADPH oxidases provides an acute "danger signal" to the surrounding mucosa that triggers an initial influx of innate immune cells. Thus, the authors demonstrate for the first time to our knowledge that pollens produce ROS and that such production contributes to the activation of an immune response.
NADPH oxidases in physiology and pathology
Although the pollen NADPH oxidase in question (9) has not yet been genetically identified, its properties place it very likely within a growing family of gp91phox homologs, the Nox/Duox family (10) (11) (12) . While characterized initially in neutrophils and macrophages, it is now clear that related NADPH oxidases are expressed in a variety of eukaryotic tissues and in species of plants, insects, nematodes, amoeba, and vertebrates. In animals, their biological roles have been defined only in a small number of cases such as the well-documented role of the phagocyte NADPH oxidase in host defense (13) , the role of Nox3 in otolith biogenesis in the inner ear (14, 15) , and the role of Duox2 in thyroid hormone biosynthesis (16) . In addition, there is growing evidence in support of a role for these enzymes in generating ROS that serve as diffusible signals required for a variety of cellular functions. Indeed, ROS have been implicated in signaling apoptosis, mitogenic responses, angiogenesis, smooth muscle hypertrophy, differentiation, and immune signaling. In plants, NADPH oxidases function in host defense (17) , stomatal closure (18) , and root hair tip growth where they play a role in polarized cell growth (19) . Root hairs are 1 of 2 highly differentiated tip growing structures in plants, the other of which are pollen tubes (20) . Given the analogous polarized growth characteristics of the 2 cell types, it seems plausible that pollen tubes also contain an NADPH oxidase that may participate in polarized growth. Thus the NADPH oxidase of pollen may be a developmental holdover derived from the cell of origin. Alternatively, as suggested by Boldogh et al. (9) , seed germination requires ROS; it is possible that ROS is also required for pollen germination.
Despite whatever advantage it confers for the plant, when the pollen oxidase comes into contact with the human airway, pathological responses occur. This is not entirely surprising, given that ROS have long been documented to cause molecular damage and aberrant signaling, collectively referred to as oxidative stress. In this regard, the discovery of a pathogenic role for pollen NADPH oxidase in the allergic response adds to a growing list of proposed pathological roles for members of this family of enzymes. While the function of these enzymes is likely to be necessary for maintenance of normal signaling, abnormal expression or function of Nox/Duox enzymes has been proposed to be involved in the pathogenesis of hypertension, atherosclerosis, diabetes, and cancer. The work by Boldogh et al. (9) implies that drugs designed to inhibit the pollen NADPH oxi-
Figure 1
A binary model for pollen-induced inflammation. Pollen triggers an adaptive immune response through the process of antigen presentation by professional antigen-presenting cells. This response also triggers recruitment of granulocytes including eosinophils and results in inflammation, which is due in part to the production of ROS by the eosinophil NADPH oxidase. In this issue of the JCI, Boldogh and colleagues (9) demonstrate that pollen has its own NADPH oxidase activity (referred to here as pollen oxidase, POX) that induces local oxidative stress and IL-8 secretion and triggers early recruitment of eosinophils even in the total absence of an adaptive immune response.
dase may provide a new therapeutic avenue to block allergic inflammation at its earliest known step and help those of us who live in the pollen belt to better appreciate the arrival of spring.
